BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Tátrai P, Krajcsi P. Prediction of Drug-Induced Hyperbilirubinemia by In Vitro Testing. Pharmaceutics 2020;12:E755. [PMID: 32796590 DOI: 10.3390/pharmaceutics12080755] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 1.7] [Reference Citation Analysis]
Number Citing Articles
1 Özvegy-Laczka C, Ungvári O, Bakos É. Fluorescence-based methods for studying activity and drug-drug interactions of hepatic solute carrier and ATP binding cassette proteins involved in ADME-Tox. Biochem Pharmacol 2023;209:115448. [PMID: 36758706 DOI: 10.1016/j.bcp.2023.115448] [Reference Citation Analysis]
2 Loshkova EV, Doroshenko IV, Yankina GN, Rafikova YS, Terentyeva AA, Zhelev VA, Anfinogenova OB, Khavkin AI, Odinaeva ND, Kondratieva EI, Lyulka TS, Bozhenko EA, Prudnikova VK, Rebrienko M.. Gilbert’s syndrome as a model for studying the effects of bilirubin. jour 2023. [DOI: 10.31146/1682-8658-ecg-206-10-126-141] [Reference Citation Analysis]
3 Ruan Z, Li D, Chen X, Qiu Z. Association of serum total bilirubin and potential predictors with mortality in acute respiratory failure: A retrospective cohort study. Heart Lung 2023;57:12-8. [PMID: 35987112 DOI: 10.1016/j.hrtlng.2022.08.006] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
4 Tátrai P, Erdő F, Krajcsi P. Role of Hepatocyte Transporters in Drug-Induced Liver Injury (DILI)-In Vitro Testing. Pharmaceutics 2022;15. [PMID: 36678658 DOI: 10.3390/pharmaceutics15010029] [Reference Citation Analysis]
5 Sun X, Yang J, Su D, Wang C, Wang G. Highly Efficient Adsorption of Bilirubin by Ti3 C2 Tx MXene. Chem Asian J 2021;16:1949-55. [PMID: 34041869 DOI: 10.1002/asia.202100332] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
6 Izat N, Sahin S. Hepatic transporter-mediated pharmacokinetic drug-drug interactions: Recent studies and regulatory recommendations. Biopharm Drug Dispos 2021;42:45-77. [PMID: 33507532 DOI: 10.1002/bdd.2262] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]